Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations

Clinical trial NCT02446691 · COMPLETED

Trial details

NCT number: NCT02446691
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Infections, Meningococcal

Start date: 2015-07-13
Primary completion: 2017-12-28
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.